Litcius/Paper detail

Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma

Lindsey Wang, Nathan A. Berger, Rong Xu

2021JAMA Network Open45 citationsDOIOpen Access PDF

Abstract

This cohort study assesses the risk of breakthrough SARS-CoV-2 infection and hospitalization among fully vaccinated patients with multiple myeloma.

Topics & Concepts

Multiple myelomaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakVirologyImmunologyInternal medicineInfectious disease (medical specialty)DiseaseOutbreakCOVID-19 and healthcare impactsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma | Litcius